Blaids BlaidsX Pro vs Otofonix Groove

The Blaids BlaidsX Pro is a behind-the-ear amplification product that earns a B grade with a SoundScore of 3.4/5 in our lab testing, ranking #4 of 8 devices in the Amplification Product category. Priced at $549, it sits in the premium amplifier tier. This device's standout strength is speech clarity in quiet environments, scoring 3.3/5—a solid result that sits 1.21 points above the category average of 2.11/5. For users who primarily need help hearing conversations in calm settings like home or one-on-one discussions, this represents meaningful benefit over many competing amplifiers. However, the BlaidsX Pro shows limitations in other areas. Speech in noise performance is low at 1.2/5, slightly below the category average. Music streaming scored 0.0/5, falling 1.16 points below the category average—users who want to stream audio from their phone should look elsewhere. Feedback handling is solid in absolute terms at 3.3/5, though this sits below the category average of 4.28/5. The BlaidsX Pro uses disposable batteries and does not offer app-based customization or Bluetooth streaming capabilities. It's best suited for users who prioritize speech understanding in quiet environments and prefer a straightforward, no-frills amplification solution. Those needing robust performance in noisy situations or streaming functionality should consider alternatives like the Sennheiser Conversation Clear Plus, which scored 4.04/5 in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.